
Salts and Derivatives of Active Pharmaceutical Ingredients (API)
The salts of Active Pharmaceutical Ingredients (APIs) are compounds formed by the reaction of an acid with a base, resulting in an ionic equilibrium. These salts often improve the solubility and stability of APIs, facilitating their absorption in the body. API derivatives are chemical variants of an active ingredient that may have enhanced or modified properties to optimise therapeutic efficacy. API salts are used in the formulation of oral, injectable, and topical medications. Additionally, API derivatives can improve the pharmacokinetics of drugs, such as enabling controlled release of active substances.
At CymitQuimica, we provide API salts and derivatives with the necessary purity and quality for research and pharmaceutical formulation development.
Found 79624 products of "Salts and Derivatives of Active Pharmaceutical Ingredients (API)"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
3-O-Methylmethyldopa
CAS:Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormula:C11H15NO4·H2OColor and Shape:White PowderMolecular weight:225.10011Ecamsule Related Compound D (((1SR,4RS)-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonic acid)
CAS:Halogenated, sulfonated, nitrated or nitrosated derivatFormula:C10H16O4SColor and Shape:White Beige PowderMolecular weight:232.07693Nateglinide Related Compound C (N-(cis-4-isopropylcyclohexanecarbonyl)-D-phenylalanine)
CAS:Aromatic cyclic amides (including cyclic carbamates) anFormula:C19H27NO3Color and Shape:White PowderMolecular weight:317.19909Famotidine Related Compound F (3-[[2-(diaminomethyleneamino)thiazol-4-yl]methylthio]propanoic acid)
CAS:Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structureFormula:C8H12N4O2S2Color and Shape:White PowderMolecular weight:260.04017Ethyl Benzoate
CAS:Benzoic acid, its salts and estersFormula:C9H10O2Color and Shape:Colorless LiquidMolecular weight:150.06808Brinzolamide Related Compound B ((R)-4-Amino-2-(3-methoxypropyl)-3,4-dihydro-2H-thieno[3,2-e][1,2]thiazine-6-sulfonamide 1,1-dioxide oxalate)
CAS:Sulfonamides, nesoiFormula:C10H17N3O5S3·C2H2O4Color and Shape:Off-White SolidMolecular weight:445.49Rivaroxaban isomer (4-(4-(((2-(5-chlorothiophen-2-yl)-4,5-dihydrooxazol-5-yl)methyl)amino)phenyl)morpholin-3-one)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C18H18ClN3O3SColor and Shape:White Off-White SolidMolecular weight:391.07574Trifluridine Related Compound A (5-Carboxy-2'-deoxyuridine)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C10H12N2O7Color and Shape:White Off-White PowderMolecular weight:272.06445Telmisartan Related Compound A (1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzo[d]imidazole monohydrate)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C19H20N4·H2OColor and Shape:Off-White SolidMolecular weight:322.17936Quinapril Related Compound A (Ethyl [3S-[(2R*), 3a, 11ab]]-1,3,4,6,11,11a-hexahydro-3-methyl-1,4-dioxo-a-(2-phenylethyl)-2H-pyrazino[1,2-b]isoquinoline-2-acetate)
CAS:Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFormula:C25H28N2O4Color and Shape:White PowderMolecular weight:420.20491Betamethasone Dipropionate Related Compound B (9-Fluoro-11β,21-dihydroxy-16β-methyl-3,20-dioxopregna-1,4-diene-17-yl propionate)
CAS:Halogenated derivatives of adrenal cortical hormonesFormula:C25H33FO6Color and Shape:White PowderMolecular weight:448.22612Vigabatrin Related Compound A (5-vinylpyrrolidin-2-one)
CAS:Amino-acids (excluding aromatic) and their esters other than those containing more than one kind of oxygen function, nesoiFormula:C6H9NOColor and Shape:Clear Colorless Reddish-Brown LiquidMolecular weight:111.06841Clonazepam Related Compound B (2-Amino-2'-chloro-5-nitrobenzophenone)
CAS:Amino-aldehydes, amino-ketones and amino-quinones, other than those containing more than one kind of oxygen function; salts thereof, nesoiFormula:C13H9ClN2O3Color and Shape:Yellow PowderMolecular weight:276.030173-Amino-2,4,6-triiodobenzoic Acid
CAS:Aromatic amino-acids and their esters, other than those containing more than one kind of oxygen function, not elsewhere specified or includedFormula:C7H4I3NO2Color and Shape:Light Yellow Amorphous PowderMolecular weight:514.73762Abacavir Related Compound D (N6-Cyclopropyl-9-{(1R,4S)-4-[(2,5-diamino-6-chloropyrimidin-4-yloxy)methyl]cyclopent-2-enyl}-9H-purine-2,6-diamine)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormula:C18H21ClN10OColor and Shape:Red Orange Brown PowderMolecular weight:428.15883Zidovudine Related Compound C (thymine)
CAS:Compounds containing a pyrimidine ring (whether or notFormula:C5H6N2O2Color and Shape:PowderMolecular weight:126.04293Quetiapine Related Compound B (11-(Piperazin-1-yl)dibenzo[b,f][1,4]thiazepine dihydrochloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C17H17N3S·2HClColor and Shape:Off-White PowderMolecular weight:295.11432Almotriptan Related Compound C (N-methyl-2-{5-[(pyrrolidin-1-ylsulfonyl)methyl]-1H-indol-3-yl}ethanamine)
CAS:Aromatic or modified aromatic drugs with nitrogen heteroFormula:C16H23N3O2SColor and Shape:SolidMolecular weight:321.1511Glyburide Related Compound B (methyl-[[4-[2-[(5-chloro-2-methoxybenzoyl)-amino]ethyl]phenyl]sulfonyl]carbamate) (AS)
CAS:Sulfonamides, excluding drugsFormula:C18H19ClN2O6SColor and Shape:PowderMolecular weight:426.06524Almotriptan Related Compound A ({3-[2-(Dimethylamino)ethyl]-5-[(pyrrolidine-1-yl)sulfonylmethyl]-1H-indol-1-yl}methanol)
CAS:Sulfonamides, nesoiFormula:C18H27N3O3SColor and Shape:White Crystalline PowderMolecular weight:365.17731

